Related Experiment Videos
Drug-induced steatohepatitis.
R Todd Stravitz1, Arun J Sanyal
1Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, 1200 East Broad Street, Room 1496, Richmond, VA 23298, USA. rstravit@hsc.vcu.edu
Clinics in Liver Disease
|July 26, 2003
Summary
Certain drugs like amiodarone can cause liver damage resembling alcoholic liver disease or non-alcoholic steatohepatitis (NASH). These drugs target mitochondria, disrupting energy production and fat breakdown, leading to liver injury.
Area of Science:
- Hepatology
- Toxicology
- Biochemistry
Background:
- Drug-induced liver injury (DILI) is a significant clinical concern.
- Steatohepatitis, characterized by liver inflammation and fat accumulation, can be caused by various factors, including alcohol, metabolic dysfunction, and certain medications.
Purpose of the Study:
- To investigate the mechanisms by which specific drugs induce steatohepatitis.
- To compare the pathogenetic pathways of drug-induced steatohepatitis with non-alcoholic steatohepatitis (NASH).
Main Methods:
- Review of literature on drug-induced steatohepatitis.
- Analysis of pathogenetic mechanisms of known steatogenic drugs.
- Comparison of histological findings in drug-induced steatohepatitis and NASH.
Main Results:
- Amiodarone, perhexiline, and DH unequivocally induce steatohepatitis with features similar to alcoholic liver disease or NASH.
- These drugs share common pathogenetic mechanisms, primarily targeting mitochondrial ATP production and fatty acid catabolism.
- Steroid hormones may exacerbate NASH through similar pathways.
- Mitochondrial injury and subsequent lipid peroxidation are implicated in the histological findings of drug-induced steatohepatitis.
Conclusions:
- Specific drugs can independently cause steatohepatitis through mitochondrial dysfunction.
- Understanding these mechanisms is crucial for diagnosing and managing DILI.
- Further research is needed to elucidate the progression from drug-induced steatosis to steatohepatitis and fibrosis.